" class="no-js "lang="en-US"> Joseph La Barge - Medtech Alert
Thursday, March 28, 2024
Joseph La Barge

Joseph La Barge

About Joseph La Barge

C-suite executive with extensive experience in building life science companies. Effective leader with track record of leading business development, finance, legal and compliance, government affairs and public policy.

Related Story

NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease

September 7 2021

NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG;OTCQX: RHHBY) today announced a […]